Tetanus Antitoxin Vial

Tetanus Antitoxin provides quick, short-term tetanus protection whenever a non-immunized animal suffers a deep penetrating wound that has or may become contaminated with soil. It may also be administered to animals following castration, docking, and other operations performed on premises where tetanus infection has been a problem. Vaccination with Tetanus Toxoid is recommended for healthy domestic animals not infected with tetanus, to establish an active immunity for prevention against disease. Tetanus Antitoxin is prepared from the blood of healthy horses that have been hyperimmunized. It is recommended for use as an aid in the prevention and treatment of tetanus in animals.

INDICATION
Tetanus Antitoxin is used for prophylaxis and treatment of Tetanus. Tetanus Antitoxin use is also recommended in case of surgical operations involving reopening of old scars, piles and fistuale and those in which faecal contamination is likely.

Therapeutic Use:
For therapy, large doses of antitoxin should be given very slowly by intravenous route followed by smaller weekly doses intramuscularly as required. Some physicians prefer a smaller initial so intramuscularly. Active immunisation may be initiated when the patient is cured of the illness.

COMPOSITION
Prophylactic Use:
Tetanus antitoxin is given as prophylaxis to the persons at risk with infected wounds, wounds contaminated with soil or mud, deep or punctured wounds and wounds with devitalising tissue damages. A dose of should be given subcutaneously or intramuscularly as early as possible after the wound is received. In severe wounds, the dose may be doubled or trebled and the antitoxin injected in two or three places around the wound. Along with prophylactic passive immunisation, it is advisable to initiate active immunisation with adsorbed Tetanus toxoid.

Tetanus Antitoxin Vial Highlights:

• SKU: 17401
• Manufacturer: Colorado Serum Company
• Available in 1 dose vial, 10 dose vial, and 10x1 dose box.
• Etanus Antitoxin is used for prophylaxis and treatment of Tetanus.
• Active immunisation may be initiated when the patient is cured of the illness.
• it is advisable to initiate active immunisation with adsorbed Tetanus toxoid.
• Tetanus antitoxin is given as prophylaxis to the persons at risk with infected wounds.
• A dose of should be given subcutaneously or intramuscularly as early as possible after the wound is received.